Pfizer’s Prempro Didn’t Cause Woman’s Cancer, Jury Concludes
This article is for subscribers only.
Pfizer Inc.’s Prempro menopause drug wasn’t the cause of a West Virginia woman’s breast cancer, a jury ruled today in rejecting her claim for damages.
Jurors in federal court in Charleston, West Virginia, found that hormone therapy medicines made by Pfizer’s Wyeth and Upjohn units weren’t a cause in the development of Leah Royce Hines’s breast cancer.